<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02494375</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL15_0219</org_study_id>
    <nct_id>NCT02494375</nct_id>
  </id_info>
  <brief_title>Sleep and Type 1 Diabetes</brief_title>
  <acronym>SLEEPT1D</acronym>
  <official_title>Sleep and Glycemic Control in Type 1 Diabetic Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary goal of the study is to determine whether insufficient sleep is associated with
      poor glycemic control in type 1 diabetic children. Secondary goals aim to determine whether
      salivary amylase could be an easily accessible and non-invasive biomarker of sleep loss and
      somnolence, and whether insufficient sleep is linked to body composition. Sleep
      characteristics, glycemic control, salivary amylase and body composition will be assessed 3
      times, at 3-4 months intervals, in 82 type 1 diabetic children.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 28, 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Association between HbA1c and sleep characteristics</measure>
    <time_frame>Month 3, Month 6 and Month 9</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose levels</measure>
    <time_frame>Month 3, Month 6 and Month 9</time_frame>
    <description>3 daily pre- and post- meal glucose levels over a 3-day period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily salivary amylase variation (Enzyme Activity)</measure>
    <time_frame>Month 3, Month 6 and Month 9</time_frame>
    <description>Assessment of salivary amylase levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (BMI fat and lean mass percentage)</measure>
    <time_frame>Month 3, Month 6 and Month 9</time_frame>
    <description>Assessment of body composition</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Sleep and glucose assessement.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sleep and glucose assessments</intervention_name>
    <description>Sleep characteristics, glycemic control, salivary amylase and body composition will be assessed 3 times, at 3-4 months intervals</description>
    <arm_group_label>Sleep and glucose assessement.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Female and male type 1 diabetic children and adolescents who are followed at the Woman,
        Mother and Child's Hospital (Hôpital Femme Mère Enfant : HFME) of Bron, France.

        Exclusion Criteria:

          -  Refusal of consent of the parents or the child or the adolescent

          -  Pregnancy

          -  Concomitant pathology that severly impacts sleep

          -  Implanted electrical stimulation device

          -  Diagnosis of type 1 diabetes &lt;1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2015</study_first_submitted>
  <study_first_submitted_qc>July 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2015</study_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep</keyword>
  <keyword>glycemic control</keyword>
  <keyword>type 1 diabetes</keyword>
  <keyword>amylase</keyword>
  <keyword>body composition</keyword>
  <keyword>lean</keyword>
  <keyword>overweight</keyword>
  <keyword>obese</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

